Multi‐Center, Multi‐Vendor Validation of Simultaneous MRI ‐Based Proton Density Fat Fraction and R2 * Mapping Using a Combined Proton Density Fat Fraction‐ R2 * Phantom
Journal of Magnetic Resonance Imaging · 2025-09 · 62 (3) · 800-811
DOI: 10.1002/jmri.29775 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 18.04.2025. Verfasst von Jitka Starekova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Adipose Tissue. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIBIB NIH HHS, Cancer Prevention and Research Institute of Texas, National Institute of Health Sciences.
Abstract (Originalsprache)
Background
Fat and iron deposition confound measurements of R2* and proton density fat fraction (PDFF), respectively, yet their combined impact on reproducibility is poorly understood.
Purpose
To evaluate the multi‐center, multi‐vendor reproducibility of PDFF and R2* quantification using a PDFF‐R2* phantom. Study Type Prospective multi‐center, phantom study. Phantom Commercial PDFF‐R2* phantom with simultaneously controlled combination of PDFF (0%–30%) and R2* (50–600 s −1 ) values. Field Strength/Sequence 1.5‐T and 3‐T, three‐dimensional ( 3D ) multi‐echo, spoiled‐gradient‐echo sequences, in four different centers, each with a different vendor. Assessment Two acquisition protocols were used, optimized for moderate R2* (Protocol 1) and high R2 * (Protocol 2), respectively. The phantom was imaged multiple times at one of the centers to assess its stability. Statistical Tests Intraclass correlation coefficient (ICC), linear regression analysis, reproducibility coefficient (RDC) and repeatability coefficient (RC).
Results
Excellent agreement was observed for PDFF measurements between centers, vendors, field strengths, and protocols (ICC = 0.97). Stratified by protocol, excellent agreement was observed, with ICC = 0.96 (RDC = 6.2%) for Protocol 1 and ICC = 0.99 (RDC = 3.8%) for Protocol 2. Increased variability in PDFF measurements was observed with increasing PDFF and especially with higher R2*. Excellent agreement was observed for R2* between centers, vendors, field strengths, and protocols (ICC = 0.99). Stratified by protocol, strong agreement was observed, with ICC = 0.988 (RDC = 66.7 s −1 ) for Protocol 1 and ICC = 0.99 (RDC = 57.7 s −1 ) for Protocol 2. Higher variability in R2* measurements was observed in vials with higher PDFF or R2*. Stability tests demonstrated an ICC = 1.0 for PDFF and R2*, and RC of 0.4% for PDFF and 12 s −1 for R2*. Data Conclusion Excellent PDFF and R2* reproducibility was observed across centers, vendors, field strengths, and acquisition protocols. Reproducibility decreased slightly with increasing PDFF and R2*, especially for PDFF measurements in vials with high R2*. Evidence Level N/A. Technical Efficacy Stage 1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Calimetrix, Madison, Wisconsin, USA.
- Department of Radiology, University of California-San Diego, La Jolla, California, USA.
- Canon Medical Systems, Tustin, California, USA.
- Department of Radiology, University of Texas Southwestern, Dallas, Texas, USA.
- Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Jitka Starekova, David Rutkowski, Won C Bae, Hung Do, Ananth J Madhuranthakam, Vadim Malis, Sheng Qing Lin, Suraj Serai, Takeshi Yokoo, Scott B Reeder, Diego Hernando
Förderung
- NIBIB NIH HHS
- Cancer Prevention and Research Institute of Texas
- National Institute of Health Sciences
- NCI NIH HHS
- Small Business Innovation Research
Zitieren
APA
Starekova, J., Rutkowski, D., Bae, W. C., Do, H., Madhuranthakam, A. J., Malis, V., Lin, S. Q., Serai, S., Yokoo, T., Reeder, S. B., Brittain, J. H., & Hernando, D. (2025). Multi‐Center, Multi‐Vendor Validation of Simultaneous MRI ‐Based Proton Density Fat Fraction and R2 * Mapping Using a Combined Proton Density Fat Fraction‐ R2 * Phantom. Journal of Magnetic Resonance Imaging, 62(3), 800-811. https://doi.org/10.1002/jmri.29775
Vancouver
Starekova J, Rutkowski D, Bae WC, Do H, Madhuranthakam AJ, Malis V, et al. Multi‐Center, Multi‐Vendor Validation of Simultaneous MRI ‐Based Proton Density Fat Fraction and R2 * Mapping Using a Combined Proton Density Fat Fraction‐ R2 * Phantom. Journal of Magnetic Resonance Imaging. 2025;62(3):800-811. doi:10.1002/jmri.29775
BibTeX
@article{Starekova2025,
author = {Starekova, Jitka and Rutkowski, David and Bae, Won C and Do, Hung and Madhuranthakam, Ananth J and Malis, Vadim and Lin, Sheng Qing and Serai, Suraj and Yokoo, Takeshi and Reeder, Scott B and Brittain, Jean H and Hernando, Diego},
title = {Multi‐Center, Multi‐Vendor Validation of Simultaneous MRI ‐Based Proton Density Fat Fraction and R2 * Mapping Using a Combined Proton Density Fat Fraction‐ R2 * Phantom},
journal = {Journal of Magnetic Resonance Imaging},
year = {2025},
volume = {62},
number = {3},
pages = {800--811},
doi = {10.1002/jmri.29775}
}
EUVIMED